bpc-157 for bulging disc back pain evidence The Ailment of Our Backbone: Discs Statistics Discogenic Back Pain and the
Description
Saka, E

Published in vitro research characterises its molecular interactions with VEGFR2 (vascular endothelial growth factor receptor 2), demonstrating measurable binding affinity profiles under controlled laboratory conditions
&srotate=0)
What is BPC-157 and why does Gary Brecka talk about it

Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy

That's the basic idea

The two primary methods are subcutaneous (Sub-Q) and intramuscular (IM)